Komori

Notice Regarding Receipt of Dividends from a Consolidated Subsidiary

当社が連結子会社などから合計544百万円の配当金を受け取った。受取配当金は当社の個別決算では営業収益に計上されるが、連結決算への影響はない。

Worth reading
38Recurring
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
544
¥ million
Wording
Definitive
How definitive the wording is.

Dividend per share

Total dividendsTotal amount payable to all shareholders¥544 million
Dividend per share
ItemDetails
Total dividendsNot disclosed → ¥544 million
Items this document does not state (11)
Dividend per shareTotal Annual DividendsPrevious-period results (per share)Record dateEffective dateSource of dividendsBreakdown of Regular, Commemorative and Special DividendsPayout ratioDividend policyWhether Submission to the General Meeting of Shareholders Is RequiredFiscal Period Covered

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

受取配当金が当社の財政状態、経営成績及びキャッシュ・フローに著しい影響を与える事象に該当し、臨時報告書の提出要件に該当するため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Receipt of Dividends from a Consolidated Subsidiary | Pharmarise Holdings Corporation (2796) timely disclosure | Komori